Health Invest Partners Ab has filed its 13F form on August 14, 2024 for Q2 2024 where it was disclosed a total value porftolio of $160 Million distributed in 38 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $24.6M, Unitedhealth Group Inc with a value of $16.1M, Merck & Co., Inc. with a value of $14M, Thermo Fisher Scientific Inc. with a value of $10.8M, and Amgen Inc with a value of $8.62M.
Examining the 13F form we can see an decrease of $1.59M in the current position value, from $161M to 160M.
Below you can find more details about Health Invest Partners Ab portfolio as well as his latest detailed transactions.